OR WAIT 15 SECS
This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
eBooks Volume 28, Issue 14
Assessing a drug candidate’s suitability during preformulation is essential to minimize the risk of costly downstream failure. Stability is a defining feature of biotherapeutic performance; measuring formulation stability during early-phase screening allows developers to make robust predictions of suitability for further development. Read this article and other articles in